UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma

NCT06698744 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Replaced by study by different sponsor

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma, Refractory

Interventions

BIOLOGICAL: UF-KURE-BCMA CAR T-cells
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

David Wald